xbird uses an AI-powered three-step process to provide patients with personalized therapy support and improve adherence.
xbird is tracked in the Tech.eu funding database. Based in Berlin, Germany; active in Healthtech. Acquired by Glooko in 2022. Data as of 27 Aug 2026.
